ONE-YEAR PATIENT-REPORTED PERSISTENCE TO ANTIRESORPTIVE TREATMENT IN A FRACTURE LIAISON SERVICE- THE LUCKY BONE™ PROGRAM

Author(s)

Senay A¹, Delisle J², Raynauld J³, Banica A², Troyanov Y², Beaumont P², Giroux M⁴, Jodoin A², Laflamme Y², Leduc S², MacThiong J², Malo M², Maurais G², Nguyen H⁴, Parent S², Ranger P², Rouleau D², Perreault S¹, Fernandes JC²
¹Université de Montréal, Montreal, QC, Canada, ²Hôpital du Sacré-Coeur de Montréal, Montreal, QC, Canada, ³Institut de rhumatologie de Montréal, Montreal, QC, Canada, ⁴Hôpital Jean-Talon, Montreal, QC, Canada

Presentation Documents

PHS68--strong-u-senay-a-u-sup-1-sup-strong-delisle-j-sup-2-sup-raynauld-j-sup-3-sup-banica-a-sup-2-sup-troyanov-y-sup-2-sup-beaumont-p-sup-2-sup-giroux-m-sup-4-sup-jodoin-a-sup-2-sup-laflamme-y-sup-2-sup-leduc-s-sup-2-sup-macthiong-j-sup-2- ...

OBJECTIVES: Fragility fractures caused by osteoporosis can be prevented by the prolonged intake of antiresorptive drugs. However, persistence to treatment is known to be suboptimal. Secondary fracture prevention through a Fracture Liaison Service (FLS) could help resolve this issue. This study’s objective was to assess patient-reported persistence to antiresorptive therapy after 12 months of follow-up in a FLS (Lucky Bone™). METHODS: Patients (men and women)

Conference/Value in Health Info

2016-10, ISPOR Europe 2016, Vienna, Austria

Value in Health, Vol. 19, No. 7 (November 2016)

Code

PHS68

Topic

Patient-Centered Research

Topic Subcategory

Adherence, Persistence, & Compliance, Patient-reported Outcomes & Quality of Life Outcomes

Disease

Musculoskeletal Disorders

Explore Related HEOR by Topic

Patient-Centered Research

Presentation